Member access

4-Traders Homepage  >  Shares  >  Euronext Alternext  >  Neovacs    ALNEV   FR0004032746

NEOVACS (ALNEV)

364
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Alternext
04/13/2015 04/14/2015 04/15/2015 04/16/2015 04/17/2015 Date
1.08(c) 1.12(c) 1.08(c) 1.07(c) 1.05(c) Last
116 963 562 629 185 061 49 481 64 581 Volume
+2.86% +3.70% -3.57% -0.93% -1.87% Change
More quotes
Financials (€)
Sales 2015 5,03 M
EBIT 2015 -4,83 M
Net income 2015 -6,33 M
Debt 2015 1,39 M
Yield 2015 -
Sales 2016 5,03 M
EBIT 2016 -10,2 M
Net income 2016 -6,33 M
Debt 2016 8,25 M
Yield 2016 31,7%
PER 2015 -
PER 2016
EV / Sales 2015 5,23x
EV / Sales 2016 6,59x
Capitalization 24,9 M
More Financials
Company
Neovacs SA is a biotechnology company.It focuses on an active immunotherapy technology platform with applications in the treatment of autoimmune and inflammatory diseases and cancer.It focuses on development on two Kinoids: Tumor Necrosis Factor-Kinoid and Interferon-Kinoid.The Tumor Necrosis... 
More about the company
Surperformance© ratings of Neovacs
Trading Rating : Investor Rating :
More Ratings
Latest news on NEOVACS
04/14 NEOVACS : TO PRESENT AT CHINA BIO PARTNERING FORUM (DGAP News)
04/14 NEOVACS : to Present at ChinaBio Partnering Forum
04/14 NEOVACS : To present at china bio partnering forum
04/14 NEOVACS : TO PRESENT AT CHINA BIO PARTNERING FORUM (DGAP News)
04/14 NEOVACS : to Present at ChinaBio Partnering Forum
04/01 NEOVACS : Stellar Biotechnologies and Neovacs S.A. Expand KLH Supply Relationshi..
04/01 NEOVACS : Stellar Biotechnologies and Neovacs S.A. Expand KLH Supply Relationshi..
04/01 NEOVACS : Stellar Biotechnologies and Neovacs S.A. Expand KLH Supply Relationshi..
More news
Sector news : Biotechnology & Medical Research - NEC
04/17 INCYTE : Emerging Development Pipeline Described in Eleven Abstracts at 2015 AAC..
04/16 QIAGEN NV : N.V. : to Report First Quarter 2015 Results
04/16 Receptos Reports Positive Results for the Maintenance Period of the Phase 2 T..
More sector news : Biotechnology & Medical Research - NEC


Comments 
Advertisement
Chart NEOVACS
Duration : Period :
Neovacs Technical Analysis Chart | ALNEV | FR0004032746 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF